--- title: "Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/222315344.md" description: "Thermo Fisher Scientific (TMO) has outperformed the market over the past decade, achieving an average annual return of 15.26%, exceeding the market by 3.93%. With a current market capitalization of $40 billion, an investment in TMO stock made 10 years ago would be worth $225.50 today, highlighting the significant impact of compounded returns on investment growth." datetime: "2024-12-13T20:59:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/222315344.md) - [en](https://longbridge.com/en/news/222315344.md) - [zh-HK](https://longbridge.com/zh-HK/news/222315344.md) --- > 支持的语言: [English](https://longbridge.com/en/news/222315344.md) | [繁體中文](https://longbridge.com/zh-HK/news/222315344.md) # Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years Thermo Fisher Scientific TMO has outperformed the market over the past 10 years by 3.93% on an annualized basis producing an average annual return of 15.26%. Currently, Thermo Fisher Scientific has a market capitalization of $200.40 billion. **Buying $1000 In TMO:** If an investor had bought $1000 of TMO stock 10 years ago, it would be worth **$4,225.50** today based on a price of $525.00 for TMO at the time of writing. ### Thermo Fisher Scientific's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. _This article was generated by Benzinga's automated content engine and reviewed by an editor._ ### 相关股票 - [Thermo Fisher Scentific (TMO.US)](https://longbridge.com/zh-CN/quote/TMO.US.md) - [Made.com Group PLC (MADE.UK)](https://longbridge.com/zh-CN/quote/MADE.UK.md) ## 相关资讯与研究 - [USA Antimicrobial Susceptibility Testing Market to Reach USD 1.8 Billion by 2035, Driven by Rising Antimicrobial Resistance and Diagnostic Innovation](https://longbridge.com/zh-CN/news/281334643.md) - [Lindsay (LNN) Q1 Earnings Report Preview: What To Look For](https://longbridge.com/zh-CN/news/281292775.md) - [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/zh-CN/news/281323250.md) - [Motor racing-Sainz urges FIA to act after Bearman's Suzuka crash](https://longbridge.com/zh-CN/news/280902777.md) - [Why Nvidia And Tesla Are Suddenly Knocking On Samsung's Door](https://longbridge.com/zh-CN/news/280999748.md)